Scott Dreyer
Corporate Officer/Principal at COLLEGIUM PHARMACEUTICAL, INC.
Net worth: 1 M $ as of 31/03/2024
Profile
Scott Dreyer is currently the Chief Commercial Officer & Executive VP at Collegium Pharmaceutical, Inc. He previously worked as the Vice President-US Hospital & Oncology Sales at Merck & Co., Inc. from 1994 to 2013.
From 2014 to 2016, he served as the Chief Marketing Officer at Biogen, Inc. He then worked as the Senior VP-Marketing & Commercial Operations at The Medicines Co. from 2016 to 2017.
Mr. Dreyer completed his undergraduate degree at the University of Messiah in 1994.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
27/03/2024 | 33,016 ( 0.10% ) | 1 M $ | 31/03/2024 |
Scott Dreyer active positions
Companies | Position | Start |
---|---|---|
COLLEGIUM PHARMACEUTICAL, INC. | Corporate Officer/Principal | 10/07/2018 |
Former positions of Scott Dreyer
Companies | Position | End |
---|---|---|
THE MEDICINES COMPANY | Sales & Marketing | 01/12/2017 |
BIOGEN INC. | Sales & Marketing | 01/09/2016 |
MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2013 |
Training of Scott Dreyer
University of Messiah | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
BIOGEN INC. | Health Technology |
COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
Private companies | 1 |
---|---|
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
- Stock Market
- Insiders
- Scott Dreyer